(3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol

C29H43N3O2 — CID 147385751

IUPAC(3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol
SMILESCc1ccc2nnn(CC(O)[C@H]3CC[C@H]4[C@@H]5CC[C@@H]6C[C@](C)(O)CC[C@]6(C)[C@H]5CC[C@]34C)c2c1
InChIInChI=1S/C29H43N3O2/c1-18-5-10-24-25(15-18)32(31-30-24)17-26(33)23-9-8-21-20-7-6-19-16-27(2,34)13-14-28(19,3)22(20)11-12-29(21,23)4/h5,10,15,19-23,26,33-34H,6-9,11-14,16-17H2,1-4H3/t19-,20+,21+,22+,23-,26?,27-,28+,29+/m1/s1
InChIKeyDLWBEVHRJUBIPB-BRHQBOFVSA-N
MW465.68 g/mol
LogP5.51
Rot. Bonds3

About (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol

(3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol (PubChem CID 147385751) has the molecular formula C29H43N3O2 and a molecular weight of 465.68 g/mol. Its IUPAC name is (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol.

Molecular Properties

Compound Name(3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol
PubChem CID147385751
Molecular FormulaC29H43N3O2
Molecular Weight465.68 g/mol
Exact Mass465.34
IUPAC Name(3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol
SMILESCc1ccc2nnn(CC(O)[C@H]3CC[C@H]4[C@@H]5CC[C@@H]6C[C@](C)(O)CC[C@]6(C)[C@H]5CC[C@]34C)c2c1
InChIInChI=1S/C29H43N3O2/c1-18-5-10-24-25(15-18)32(31-30-24)17-26(33)23-9-8-21-20-7-6-19-16-27(2,34)13-14-28(19,3)22(20)11-12-29(21,23)4/h5,10,15,19-23,26,33-34H,6-9,11-14,16-17H2,1-4H3/t19-,20+,21+,22+,23-,26?,27-,28+,29+/m1/s1
InChIKeyDLWBEVHRJUBIPB-BRHQBOFVSA-N
XLogP5.51
TPSA71.17 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500465.68
LogP ≤ 55.51
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol?
The IUPAC name of (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol (CID 147385751) is (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol.
What is the SMILES notation for (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol?
The canonical SMILES for (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol is Cc1ccc2nnn(CC(O)[C@H]3CC[C@H]4[C@@H]5CC[C@@H]6C[C@](C)(O)CC[C@]6(C)[C@H]5CC[C@]34C)c2c1.
What is the InChIKey of (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol?
The InChIKey is DLWBEVHRJUBIPB-BRHQBOFVSA-N. The full InChI is InChI=1S/C29H43N3O2/c1-18-5-10-24-25(15-18)32(31-30-24)17-26(33)23-9-8-21-20-7-6-19-16-27(2,34)13-14-28(19,3)22(20)11-12-29(21,23)4/h5,10,15,19-23,26,33-34H,6-9,11-14,16-17H2,1-4H3/t19-,20+,21+,22+,23-,26?,27-,28+,29+/m1/s1.
What are the key properties of (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol?
(3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol has a molecular weight of 465.68 g/mol, XLogP of 5.51, 3 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3R,5R,8R,9S,10S,13S,14S,17S)-17-[1-hydroxy-2-(6-methylbenzotriazol-1-yl)ethyl]-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol is sourced from PubChem (CID 147385751), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).